Cellectar Biosciences, Inc. (CLRB)
2.355
-0.16
(-6.18%)
USD |
NASDAQ |
Jun 09, 16:00
2.375
+0.02
(+0.85%)
After-Hours: 20:00
Cellectar Biosciences Shareholders Equity (Quarterly) : 4.717M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Karyopharm Therapeutics, Inc. | -265.65M |
| Forum Markets, Inc. | 168.34M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Savara, Inc. | 176.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.12M |
| Total Liabilities (Quarterly) | 6.403M |
| Debt to Equity Ratio | 0.3241 |
| Current Ratio | 1.901 |
| Net Debt Paydown Yield | -1.92% |